Zoe C. Schmiechen

Also affiliated with University of Minnesota Medical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma”.

Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma

Frontiers in Immunology(2021)10.3389/fimmu.2020.613815

N/A

0DataRank · unranked

57 citations

Ingunn M. Stromnes, Zoe C. Schmiechen

CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical Model

The Journal of Immunology(2021)10.4049/jimmunol.2000765

N/A

0DataRank · unranked

35 citations

Meagan R. Rollins, Ellen J. Spartz, Taylor D. Mesojednik, Zoe C. Schmiechen, Jackson F. Raynor +4 more

Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer

JCI Insight(2022)10.1172/jci.insight.151593

N/A

0DataRank · unranked

18 citations

Zoe C. Schmiechen, Michael T. Patterson, Ebony A. Miller, Ellen J. Spartz, Meagan R. Rollins +6 more

Tumor-specific CD4 T cells instruct monocyte differentiation in pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.09.515858

N/A

0DataRank · unranked

0 citations

Adam L. Burrack, Yingzheng Xu, Zoe C. Schmiechen, Patricia R. Schrank, Ainsley E. Kennedy +7 more

Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma

Cell Reports(2023)10.1016/j.celrep.2023.112732

N/A

0DataRank · unranked

53 citations

Adam L. Burrack, Yingzheng Xu, Grant H. Hickok, Zoe C. Schmiechen, Samuel Becker +9 more

IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-0758

N/A

0DataRank · unranked

8 citations

Hezkiel A. Nanda, Adam L. Burrack, Grant H. Hickok, Jonah Z. Butler, Eduardo Cruz-Hinojoza +14 more

IL-15 complex enhances therapeutic efficacy of anti-PD-L1 in a T cell–dependent and NK cell–independent manner in a murine model of pancreatic ductal adenocarcinoma

The Journal of Immunology(2025)10.1093/jimmun/vkaf314

N/A

0DataRank · unranked

2 citations

Alexander K. Tsai, Madeline A. Ellefson, Zoe C. Schmiechen, Brandon M. Larsen, Kristina S. Burrack +2 more

Immunotherapy promotes CD4 T cell effector function, limits Tregs, and relies on CD4 T cells to restrain excessive myeloid infiltration in a preclinical model of pancreatic cancer 2394

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.319

N/A

0DataRank · unranked

0 citations

Adam L. Burrack, Zoe C. Schmiechen, Grant H. Hickok, Ebony A. Miller, Brandon T. Larsen +4 more

Targeting Regulatory T cells controls metastatic pancreatic ductal adenocarcinoma by modulation of conventional CD4 T helper cells 3557

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1348

N/A

0DataRank · unranked

0 citations

Adam L. Burrack, Eduardo Cruz-Hinojoza, Jonah Z. Butler, Grant H. Hickok, Alexander K. Tsai +6 more

IL-15 complex with agonistic anti-CD40 + anti-PDL1 overcomes T cell exhaustion and drives a T-bet+ effector program for pancreatic ductal adenocarcinoma eradication 3573

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1361

N/A

0DataRank · unranked

0 citations

Hezkiel A. Nanda, Adam L. Burrack, Grant H. Hickok, Jonah Z. Butler, Eduardo Cruz-Hinojoza +10 more